Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines

BACKGROUND: Doxorubicin (DOX) is widely used in both human and veterinary oncology although the onset of multidrug resistance (MDR) in neoplastic cells often leads to chemotherapy failure. Better understanding of the cellular mechanisms that circumvent chemotherapy efficacy is paramount. The aim of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Vet Res
Main Authors: Levi, Michela, Salaroli, Roberta, Parenti, Federico, De Maria, Raffaella, Zannoni, Augusta, Bernardini, Chiara, Gola, Cecilia, Brocco, Antonio, Marangio, Asia, Benazzi, Cinzia, Muscatello, Luisa Vera, Brunetti, Barbara, Forni, Monica, Sarli, Giuseppe
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7814552/
https://ncbi.nlm.nih.gov/pubmed/33461558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-020-02709-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki